NCT05730205View on ClinicalTrials.gov

Effects of the Contraceptive Implant in Women With Sickle Cell Disease

PHASE4RecruitingINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 8, 2023

Primary Completion Date

June 15, 2026

Study Completion Date

June 15, 2026

Conditions
Sickle Cell Disease
Interventions
DRUG

Nexplanon 68 MG Drug Implant

Progestin contraceptive device

Trial Locations (1)

19104

RECRUITING

Penn Medicine University City, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER